MedPath

RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

RONAPREVE 300 MG + 300 MG SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

Pending
Register Number

1211601001

Prescription Type

Uso Hospitalario

Authorization Date

Nov 18, 2021

Dosage Form

SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211601001
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (2)

CASIRIVIMABActive
Quantity: 300 mg
Name: CASIRIVIMAB
IMDEVIMABActive
Quantity: 300 mg
Name: IMDEVIMAB

ATC CLASSIFICATION (3)

J06B
J06BD
J06BD07

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.